133 related articles for article (PubMed ID: 18614425)
1. Simultaneous estimation of atorvastatin and ramipril by RP-HPLC and spectroscopy.
Joseph L; George M; Rao B VR
Pak J Pharm Sci; 2008 Jul; 21(3):282-4. PubMed ID: 18614425
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of atorvastatin calcium and ramipril in capsule dosage forms by high-performance liquid chromatography and high-performance thin layer chromatography.
Panchal HJ; Suhagia BN
J AOAC Int; 2010; 93(5):1450-7. PubMed ID: 21140656
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous estimation of ramipril, acetylsalicylic acid and atorvastatin calcium by chemometrics assisted UV-spectrophotometric method in capsules.
Sankar AS; Vetrichelvan T; Venkappaya D
Acta Pharm; 2011 Sep; 61(3):283-96. PubMed ID: 21945907
[TBL] [Abstract][Full Text] [Related]
4. A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets.
Mohammadi A; Rezanour N; Ansari Dogaheh M; Ghorbani Bidkorbeh F; Hashem M; Walker RB
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):215-21. PubMed ID: 17010681
[TBL] [Abstract][Full Text] [Related]
5. Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies.
Pasha MK; Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR
Biomed Chromatogr; 2006 Mar; 20(3):282-93. PubMed ID: 16143964
[TBL] [Abstract][Full Text] [Related]
6. Stability-indicating reversed-phase liquid chromatographic method for simultaneous determination of atorvastatin and ezetimibe from their combination drug products.
Chaudhari BG; Patel NM; Shah PB; Patel LJ; Patel VP
J AOAC Int; 2007; 90(6):1539-46. PubMed ID: 18193730
[TBL] [Abstract][Full Text] [Related]
7. Validation of HPLC method for determination of atorvastatin in tablets and for monitoring stability in solid phase.
Stanisz B; Kania L
Acta Pol Pharm; 2006; 63(6):471-6. PubMed ID: 17438862
[TBL] [Abstract][Full Text] [Related]
8. Spectroscopic characterization and quantitative determination of atorvastatin calcium impurities by novel HPLC method.
Gupta LK
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Nov; 97():495-501. PubMed ID: 22842103
[TBL] [Abstract][Full Text] [Related]
9. Quantification of atorvastatin calcium in tablets by FT-Raman spectroscopy.
Mazurek S; Szostak R
J Pharm Biomed Anal; 2009 Jan; 49(1):168-72. PubMed ID: 19062220
[TBL] [Abstract][Full Text] [Related]
10. Comparison of UV and charged aerosol detection approach in pharmaceutical analysis of statins.
Nováková L; Lopéz SA; Solichová D; Satínský D; Kulichová B; Horna A; Solich P
Talanta; 2009 May; 78(3):834-9. PubMed ID: 19269437
[TBL] [Abstract][Full Text] [Related]
11. HPLC assay and pharmacokinetic study of atorvastatin in beagle dogs after oral administration of atorvastatin self-microemulsifying drug delivery system.
Shen HR; Li ZD; Zhong MK
Pharmazie; 2006 Jan; 61(1):18-20. PubMed ID: 16454200
[TBL] [Abstract][Full Text] [Related]
12. RP-HPLC method development and validation for simultaneous estimation of atorvastatin calcium and pioglitazone hydrochloride in pharmaceutical dosage form.
Peraman R; Mallikarjuna S; Ammineni P; Kondreddy Vk
J Chromatogr Sci; 2014 Oct; 52(9):1038-42. PubMed ID: 24152592
[TBL] [Abstract][Full Text] [Related]
13. In vitro availability of atorvastatin in presence of losartan.
Arayne MS; Sultana N; Haroon U; Qureshi F; Ali SA
Pak J Pharm Sci; 2006 Apr; 19(2):134-41. PubMed ID: 16751125
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a reversed-phase HPLC method for the simultaneous analysis of simvastatin and tocotrienols in combined dosage forms.
Ali H; Nazzal S
J Pharm Biomed Anal; 2009 May; 49(4):950-6. PubMed ID: 19286339
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of stability-indicating assay method by UPLC for a fixed dose combination of atorvastatin and ezetimibe.
Goel A; Baboota S; Sahni JK; Srinivas KS; Gupta RS; Gupta A; Semwal VP; Ali J
J Chromatogr Sci; 2013 Mar; 51(3):222-8. PubMed ID: 22865836
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a liquid chromatographic method for the determination of the related substances of ramipril in Altace capsules.
Hogan BL; Williams M; Idiculla A; Veysoglu T; Parente E
J Pharm Biomed Anal; 2000 Sep; 23(4):637-51. PubMed ID: 10975240
[TBL] [Abstract][Full Text] [Related]
17. Identification and quantitative determination of atorvastatin calcium polymorph in tablets using FT-Raman spectroscopy.
Skorda D; Kontoyannis CG
Talanta; 2008 Jan; 74(4):1066-70. PubMed ID: 18371751
[TBL] [Abstract][Full Text] [Related]
18. Rapid analysis of atorvastatin calcium using capillary electrophoresis and microchip electrophoresis.
Guihen E; Sisk GD; Scully NM; Glennon JD
Electrophoresis; 2006 Jun; 27(12):2338-47. PubMed ID: 16786480
[TBL] [Abstract][Full Text] [Related]
19. Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate and their degradation products in tablets.
Kadav AA; Vora DN
J Pharm Biomed Anal; 2008 Sep; 48(1):120-6. PubMed ID: 18583084
[TBL] [Abstract][Full Text] [Related]
20. Stability-indicating high-performance liquid chromatographic assay of atorvastatin with fluorescence detection.
Khedr A
J AOAC Int; 2007; 90(6):1547-53. PubMed ID: 18193731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
